Aiming to expand the body of literature on emerging trends related to cardiovascular toxicities caused by immune therapies, JACC: CardioOncology will publish a uniquely themed issue highlighting this important area. Original research manuscripts, research letters and clinical case challenges on topics spanning immune therapy and cardiovascular disease will be considered, including those focusing on epidemiology, screening, diagnosis, risk stratification and clinical management. Basic studies focused on advancing understanding of disease mechanisms and pathophysiology are also of interest. Submissions are due on or before May 1, 2022. Learn more.